Nitric oxide-still no consensus.

Abstract

When NO became available for clinical use, it seemed to hold enormous promise for newborn infants with lung disease. With regard to the term and near-term infant, the role of NO seems satisfactorily defined: Near-term and term infants with hypoxic respiratory failure unresponsive to current therapy, excluding infants with diaphragmatic hernia, should have a trial of inhaled nitric oxide. In the preterm infant, the situation is less clear with, as yet, no specific indication identified.

• Authors: David J Field
• Journal: Early human development (Early Hum Dev) Vol. 81 Issue 1 Pg. 1-4 (Jan 2005) ISSN: 0378-3782 [Print] Ireland
• PMID: 15707709 (Publication Type: Journal Article, Review)

Chemical References

• Nitric Oxide

Topics

• Humans
• Infant, Newborn
• Infant, Premature
• Nitric Oxide (therapeutic use)
• Respiratory Distress Syndrome, Newborn (drug therapy)
• Respiratory Insufficiency (drug therapy)